Thus, there is a signaling relay from CCL2/CCR2 to CCL3/CCR1 during the process of BC lung metastasis, and blocking the distal part of this signaling relay may have more impact on metastatic disease than blocking upstream targets because of likely lower toxicity [86, 87] (Table 4). This evidence concerns the gene CCL2 and breast cancer.